Colitis - trial data

Glossop, Edwards and Cobb (2000) [?] in UK reported to Novartis Animal Health on the results of a study with Tiamutin® Premix to treat and control PCS infection. A level of 100 ppm tiamulin hydrogen fumarate was used for a trial period of 12 consecutive days.
 

There were major benefits in productivity (average daily gain and feed conversion efficiency) recorded for the Tiamutin medicated group compared to the unmedicated, infected control group, as shown below:
 

Glossop determined the effect of Tiamutin® premix in the treatment of a naturally occurring colitis infection in growers. Tiamutin improved significantly at a level of 5mg/kg bw the clinical condition of pigs and prevented weight gain depression.